Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
Sponsor: Sam Tyagi
Summary
The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).
Official title: A Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCI
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2020-12-08
Completion Date
2027-08
Last Updated
2025-10-20
Healthy Volunteers
No
Interventions
Saline
Saline infusion
Ketamine
Continuous ketamine infusion at a dose of 0.2 mg/kg/hr, initiated at the induction of anesthesia and continued for 48 hours postoperatively.
Locations (1)
University of Kentucky Medical Center
Lexington, Kentucky, United States